Life sciences and healthcare companies that set out to pioneer treatments in rare and specialty disease face a unique set of challenges. Typical pitfalls for advancing an indication in this space...

Nitin Choudhary, Managing Principal of IPM.ai and Richard Wilson, Rare Disease Franchise Head for Kyowa Kirin recently spoke on overcoming patient-finding challenges through machine learning (ML)...

Conventional clinical study recruitment methods for rare diseases simply don’t work. Analyzing ICD-10 and prescription data to determine patient clusters, site selection and feasibility is...

October 14, 2021

Utilizing Augmented Intelligence to Drive Optimal Decisions Throughout the...

0

Life sciences and healthcare companies that set out to pioneer treatments in rare and specialty disease face a unique set of challenges. Typical pitfalls for advancing an indication in this space...

September 29, 2021

A New Reference Model for Clinical Study Recruitment

0

Conventional clinical study recruitment methods for rare diseases simply don’t work. Analyzing ICD-10 and prescription data to determine patient clusters, site selection and feasibility is...

August 9, 2021

IPM.ai's Clinical Trial Recruitment Solution Featured in MM&M

0

Allison Rhee of MM&M reports on IPM.ai's answer to patient finding for rare and specialty diseases through advanced AI/ML. Read the full text below: